Erratum: Therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma(International Journal of Oncology(2018)53(2627-2636)DOI: 10.3892/ijo.2018.4585)

Jorge De La Chapa, Prajjal Kanti Singha, McKay Sallaway, Kristen Self, Ranna Nasreldin, Ramesh Dasari, Matthew Hart, Alexander Kornienko, Jeremy Just, Jason A. Smith, Alex C. Bissember, Cara B. Gonzales

Resultado de la investigación: Comment/debaterevisión exhaustiva

Resumen

After the publication of the above article, the authors have realized that they failed to properly acknowledge the work performed by their Center for Innovative Drug Discovery High Throughput Screening Core Facility in the paper. The Declarations section of their paper should therefore have also included the following statement: "The UT Health San Antonio Center for Innovative Drug Discovery HTS Facility was funded in part by the Cancer Prevention Research Institute of Texas (CPRIT; grant no. RP160844)".

Idioma originalEnglish (US)
Páginas (desde-hasta)1045
Número de páginas1
PublicaciónInternational journal of oncology
Volumen56
N.º4
DOI
EstadoPublished - 2020

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Erratum: Therapeutic agents disrupting mitochondrial function in oral squamous cell carcinoma(International Journal of Oncology(2018)53(2627-2636)DOI: 10.3892/ijo.2018.4585)'. En conjunto forman una huella única.

Citar esto